Nurse Practitioner · Iowa City, IA
NPI
1750867248
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 Hawkins Dr
Iowa City, IA, 52242
Phone (319) 356-2572
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
346 services
Medicare patients, 2024
179
Average age 58
Drug cost, 2024
$2.8M
5,757 prescriptions
Company payments, 2025
$77.16
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mikhail P Shkiryak was code 99214 (office e&m - established), 98 times for 87 patients. In total Mikhail P Shkiryak billed 346 services in 10 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 98 | 87 | $46.68 | $4,574 |
| 99213 Office E&M - Established | Facility | 76 | 72 | $29.06 | $2,208 |
| 99215 Office E&M - Established | Facility | 58 | 46 | $75.68 | $4,390 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 41 | 38 | $9.35 | $383 |
| 95970 Electrical Nerve Conductivity | Facility | 37 | 22 | $9.31 | $344 |
By year: 2022 $13K for 292 services; 2023 $13K for 311 services; 2024 $13K for 346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mikhail P Shkiryak prescribed most often to Medicare patients was Levetiracetam, with 748 prescriptions and refills. In total Mikhail P Shkiryak wrote 5,757 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 748 | 1,156 | 118 | $34K |
| Lamotrigine Generic | 593 | 766 | 72 | $11K |
| Lacosamide Generic | 535 | 673 | 52 | $72K |
| Briviact Brivaracetam | 396 | 399 | 36 | $548K |
| Clobazam Generic | 270 | 287 | 30 | $37K |
| Zonisamide Generic | 233 | 282 | 30 | $8,970 |
| Aptiom Eslicarbazepine Acetate | 225 | 225 | 19 | $429K |
| Xcopri Cenobamate | 181 | 182 | 15 | $236K |
| Oxcarbazepine Generic | 155 | 257 | 24 | $9,647 |
| Divalproex Sodium Generic | 145 | 184 | 14 | $12K |
| Lorazepam Generic | 137 | 137 | 34 | $223 |
| Levetiracetam Er Levetiracetam | 135 | 192 | 20 | $8,755 |
| Lamotrigine Er Lamotrigine | 130 | 155 | 15 | $39K |
| Divalproex Sodium Er Divalproex Sodium | 121 | 154 | 14 | $6,166 |
| Clonazepam Generic | 116 | 119 | 23 | $667 |
Brand drugs: 1,462 claims; generic drugs: 4,263 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mikhail P Shkiryak $77.16 ($77.16 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $77.16.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $77.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.